BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25134863)

  • 1. Predictors of early recurrence for node-negative t1 to t2b non-small cell lung cancer.
    Kiankhooy A; Taylor MD; LaPar DJ; Isbell JM; Lau CL; Kozower BD; Jones DR
    Ann Thorac Surg; 2014 Oct; 98(4):1175-83. PubMed ID: 25134863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor recurrence after complete resection for non-small cell lung cancer.
    Taylor MD; Nagji AS; Bhamidipati CM; Theodosakis N; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2012 Jun; 93(6):1813-20; discussion 1820-1. PubMed ID: 22542070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
    Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
    Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T1/T2 non-small-cell lung cancer treated by lobectomy: does tumor anatomic location matter?
    Whitson BA; Groth SS; Andrade RS; Habermann EB; Maddaus MA; D'Cunha J
    J Surg Res; 2012 Oct; 177(2):185-90. PubMed ID: 22921916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
    Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
    Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
    Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
    Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.
    Neri S; Yoshida J; Ishii G; Matsumura Y; Aokage K; Hishida T; Nagai K
    Ann Surg; 2014 Aug; 260(2):383-8. PubMed ID: 24646539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchial resection margin length and clinical outcome in non-small cell lung cancer.
    Tomaszek SC; Kim Y; Cassivi SD; Jensen MR; Shen KH; Nichols FC; Deschamps C; Wigle DA
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1151-6. PubMed ID: 21450488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
    Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
    Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non-small cell lung cancer.
    Mohiuddin K; Haneuse S; Sofer T; Gill R; Jaklitsch MT; Colson YL; Wee J; Bueno R; Mentzer SJ; Sugarbaker DJ; Swanson SJ
    J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1169-75; discussion 1175-7. PubMed ID: 24507406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers.
    Wolf AS; Richards WG; Jaklitsch MT; Gill R; Chirieac LR; Colson YL; Mohiuddin K; Mentzer SJ; Bueno R; Sugarbaker DJ; Swanson SJ
    Ann Thorac Surg; 2011 Nov; 92(5):1819-23; discussion 1824-5. PubMed ID: 22051277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of subcentimeter non-small cell lung cancer after surgical resection: single institution experience of 105 patients.
    Jiang W; Pang X; Xi J; Chen X; Wang Q; Qian C; Fan H
    J Surg Oncol; 2014 Sep; 110(3):233-8. PubMed ID: 24888753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.